Yi-Ting Wu
Papers
1
Total Citations
3
H-Index
1
About
Dr. Yi-Ting Wu is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for complex renal malignancies. Her primary research focuses on the management of locally advanced renal cell carcinoma (RCC) with intravenous tumor thrombus (IVTT), a challenging condition affecting 4-10% of renal tumors. Dr. Wu’s major contribution lies in systematically evaluating and comparing laparoscopic and robotic-assisted approaches for these high-risk cases, demonstrating that minimally invasive methods can achieve safe oncologic outcomes while reducing patient morbidity. Her landmark 2025 systematic review, which has already garnered 3 citations, provides crucial evidence supporting the adoption of these techniques in specialized centers. Beyond this work, Dr. Wu is recognized for her efforts to standardize surgical protocols and improve perioperative care for RCC patients with IVTT. Her research has been instrumental in shifting the paradigm from traditional open surgery to less invasive alternatives, offering hope for faster recovery and better quality of life. With a growing citation impact and a reputation for rigorous methodology, Dr. Wu continues to shape the future of urologic oncology through her dedication to innovation and clinical excellence.
Research Focus
Key Achievements
Top Papers
- 1